Docoh
Loading...

STAB Statera BioPharma

News

From Benzinga Pro
Stocks That Hit 52-Week Lows On Thursday
20 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Thursday's morning trading, 152 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
6 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Thursday, 615 stocks hit new 52-week lows.
12 Health Care Stocks Moving In Tuesday's After-Market Session
4 Jan 22
Movers
Gainers
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
29 Dec 21
Pre-Market Outlook, Markets, Movers
Statera Biopharma Submits Phase 3 Clinical Trial Protocol To FDA For Investigational Treatment Of Pediatric Crohn's Disease
29 Dec 21
Biotech, News, FDA, General
Statera Biopharma, Inc. (NASDAQ:STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced submission to the U.S.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
22 Dec 21
Pre-Market Outlook, Markets, Movers
Statera Starts Dosing In Acute COVID-19 Trial
21 Dec 21
Biotech, News, Penny Stocks, Health Care, General
Statera Biopharma Inc (NASDAQ: STAB) has
12 Health Care Stocks Moving In Monday's After-Market Session
20 Dec 21
Movers
Gainers
Statera Biopharma Reports First Patient Dosed In STAT-205 Study For Acute COVID
20 Dec 21
Biotech, News, FDA, General
Initial Study to Evaluate Pharmacokinetics, Biomarkers and Safety of STAT-205 Targeting Preliminary Data 2022 FORT COLLINS, Colo., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma (NASDAQ:STAB), a leading
54 Biggest Movers From Yesterday
8 Dec 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and accessories.
12 Health Care Stocks Moving In Thursday's Intraday Session
18 Nov 21
Intraday Update, Markets, Movers
Statera BioPharma Q3 EPS $(0.47) Down From $(0.06) YoY
15 Nov 21
Earnings, News
Statera BioPharma (NASDAQ:STAB) reported quarterly losses of $(0.47) per share. This is a 683.33 percent decrease over losses of $(0.06) per share from the same period last year.
Earnings Scheduled For November 15, 2021
15 Nov 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter.

Press releases

From Benzinga Pro
Statera Biopharma Submits Phase 3 Clinical Trial Protocol to FDA for Investigational Treatment of Pediatric Crohn's Disease
29 Dec 21
Analyst Ratings, Press Releases
FORT COLLINS, Colo., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ:STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and
Statera Biopharma Announces First Patient Dosed in Study of STAT-205 for Acute COVID
20 Dec 21
Health Care, Press Releases
Initial Study to Evaluate Pharmacokinetics, Biomarkers and Safety of STAT-205 Targeting Preliminary Data 2022 FORT COLLINS, Colo., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma (NASDAQ:STAB), a leading
Statera Biopharma Announces FDA Lifts Clinical Hold on Entolimod
1 Dec 21
Health Care, Press Releases
FORT COLLINS, Colo., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ:STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and
Statera Biopharma Provides Third Quarter 2021 Financial and Corporate Update
15 Nov 21
Earnings, Press Releases
FORT COLLINS, Co., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ:STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and
Statera Biopharma, Inc. to Report Third Quarter 2021 Financial Results
9 Nov 21
News, Press Releases
FORT COLLINS, Colo., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ:STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and
Statera Biopharma Honors Pancreatic Cancer Awareness Month
1 Nov 21
Health Care, Press Releases
FORT COLLINS, Colo., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ:STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and